|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2004-12-28 Sale |
2005-01-03 07:57 am | BIOGEN IDEC INC | BIIB | Gilman Michael (EVP - Research) | 12,750 | $67.5 | $860,628 | 23,000 (Direct) | View |
| 2004-12-09 Sale |
2004-12-13 09:44 am | BIOGEN IDEC INC | BIIB | Gilman Michael (EVP - Research) | 15,263 | $65 | $992,095 | 15,524 (Direct) |
View |
| 2004-09-13 Sale |
2004-09-15 4:37 pm |
BIOGEN IDEC INC | BIIB | Gilman Michael (EVP - Research) | 30,000 | $62.5 | $1,875,000 | 14,500 (Direct) |
View |
| Transaction & Date | Reported Date | Company | Symbol | Insider Relationship |
Shares Traded | Average Price |
Total Amount | Shares Ownership | Filing |
| 2004-12-28 Exercise | 2005-01-03 07:57 am | BIOGEN IDEC INC | BIIB | Gilman Michael (EVP - Research) | 12,750 | $44.95 | $573,175 | 28,750 (Direct) |
View |
| 2004-12-09 Exercise |
2004-12-13 09:44 am | BIOGEN IDEC INC | BIIB | Gilman Michael (EVP - Research) | 15,263 | $40.93 | $624,774 | 23,287 (Direct) | View |
| 2004-09-13 Exercise | 2004-09-15 4:37 pm |
BIOGEN IDEC INC | BIIB | Gilman Michael (EVP - Research) | 30,000 | $44.54 | $1,336,200 | 44,500 (Direct) | View |
| 2004-06-15 Option Award | 2004-08-02 3:03 pm | BIOGEN IDEC INC | BIIB | Gilman Michael (EVP - Research) | 4,000 | $0 | $0 | 12,966 (Direct) | View |
| Transaction & Date |
Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2009-06-16 Option Award | 2009-06-18 5:50 pm | N/A 2019-06-16 |
EPIX Pharmaceuticals, Inc. | EPIX | Gilman Michael (Director) | 25,000 | $0.18 | 25,000 (Direct) |
View |
| 2008-05-19 Option Award |
2008-05-21 5:24 pm | N/A 2018-05-19 |
EPIX Pharmaceuticals, Inc. | EPIX | Gilman Michael (Director) | 10,000 | $1.9 | 10,000 (Direct) |
View |
| 2007-06-27 Option Award |
2007-06-29 5:25 pm |
N/A 2017-06-27 |
EPIX Pharmaceuticals, Inc. | EPIX | Gilman Michael (Director) | 10,000 | $5.2 | 10,000 (Direct) |
View |
| 2006-04-24 Option Award |
2006-04-26 11:25 am |
N/A 2016-04-24 | EPIX Pharmaceuticals, Inc. | EPIX | Gilman Michael (Director) | 25,000 | $3.92 | 25,000 (Direct) |
View |
| 2005-02-17 Option Award | 2005-02-22 3:15 pm | N/A 2015-02-17 | BIOGEN IDEC INC | BIIB | Gilman Michael (EVP - Research) | 70,000 | $67.57 | 70,000 (Direct) |
View |
| 2004-12-28 Exercise |
2005-01-03 07:57 am | N/A 2009-05-17 |
BIOGEN IDEC INC | BIIB | Gilman Michael (EVP - Research) | 7,000 | $44.54 | 0 (Direct) | View |
| 2004-12-28 Exercise |
2005-01-03 07:57 am | N/A 2010-12-15 |
BIOGEN IDEC INC | BIIB | Gilman Michael (EVP - Research) | 5,750 | $45.46 | 23,000 (Direct) | View |
| 2004-12-09 Exercise | 2004-12-13 09:44 am |
N/A 2009-05-17 |
BIOGEN IDEC INC | BIIB | Gilman Michael (EVP - Research) | 7,500 | $44.54 | 7,000 (Direct) | View |
| 2004-12-09 Exercise |
2004-12-13 09:44 am | N/A 2012-12-06 |
BIOGEN IDEC INC | BIIB | Gilman Michael (EVP - Research) | 7,763 | $37.45 | 15,524 (Direct) |
View |
| 2004-09-13 Exercise |
2004-09-15 4:37 pm |
N/A 2009-05-17 |
BIOGEN IDEC INC | BIIB | Gilman Michael (EVP - Research) | 30,000 | $44.54 | 14,500 (Direct) | View |
| 2004-06-15 Option Award | 2004-08-02 3:03 pm | N/A 2014-06-15 |
BIOGEN IDEC INC | BIIB | Gilman Michael (EVP - Research) | 25,000 | $59.39 | 25,000 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 21 Nov 2009 02:53:51 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |